Trials Sponsors Conditions Drugs Pricing

Conditions

Stroke, Acute Ischemic

Keywords

Large Vessels Occlusion (LVO)ThrombectomyBiomarkersPoint of care test (POCT)

Outcome Measures

Primary Outcomes (1)

Evaluation of the diagnosis accuracy of the algorithm LVOCheck (Specificity and sensibility)
* Biomarkers * Clinical data (gender, age, diabetes, dyslipidemia, atrial fibrillation, blood pressure) * Neurologic scales (NIHSS, RACE, GFAST, Cincinatti)
6 months

Secondary Outcomes (1)

Viability of the implement of the tool at a pre-hospital environment
6 months

Study Arms (1)

Pre-hospital and in-hospital patients

Patients recruited at the ambulance (ARM A) and at the hospital (ARM B).

Device: Large Vessel Occlusion Biomarkers Test

Interventions

Large Vessel Occlusion Biomarkers TestDevice

Duplex Point of Care test to measure the concentration of biomarkers associated to Large Vessel Occlusion in blood samples used in combination with an APP.

Pre-hospital and in-hospital patients

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodProbability Sample

Study Population

Patients with stroke code activated will be recruited at a pre-hospital and hospital environment.

You may qualify if:

I.1: Patients \> 18 years old.

Sponsors & Collaborators

Hospital Universitario Poniente
Type not reportedcollaborator
Hospital de Medina del Campo
Type not reportedcollaborator
Hospital General Río Carrión

Study Sites (16)

Complejo Hospitalario Universitario Albacete

Albacete, Spain

Hospital Universitario Poniente

Almería, Spain

Hospital Universitario Torrecárdenas

Almería, Spain

Hospital General San Jorge

Huesca, Spain

Hospital San Pedro

Logroño, Spain

Hospital General Río Carrión

Palencia, Spain

Hospital General de Segovia

Segovia, Spain

MeSH Terms

Conditions

Ischemic Stroke

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

Ana Barragán Prieto
Hospital Universitario Virgen Macarena
PRINCIPAL INVESTIGATOR

Enrollment

355 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

April 5, 2023

First Posted

April 27, 2023

Study Start

April 15, 2023

Actual (reported)

Potential Use of a POCT for the Direct Transfer of Stroke Patients From the Ambulance to the Thrombectomy Center

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

Study Start

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (1)

Pre-hospital and in-hospital patients

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (16)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

Study Start

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (1)

Pre-hospital and in-hospital patients

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (16)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations